Safety and efficacy of N‐acetylcysteine in children with non‐acetaminophen‐induced acute liver failure
Christine Kortsalioudaki, Rachel M. Taylor, Paul Cheeseman, Sanjay Bansal, Giorgina Mieli‐Vergani, Anil Dhawan – 27 December 2007 – Acute liver failure (ALF) carries a high mortality in children. N‐acetylcysteine (NAC), an antioxidant agent that replenishes mitochondrial and cytosolic glutathione stores, has been used in the treatment of late acetaminophen‐induced ALF and non‐acetaminophen‐induced ALF. In our unit, NAC was introduced as additional treatment for non‐acetaminophen‐induced ALF in 1995.